TABLE 2.
Overview of Participating NIDA CTN-0002 Outpatient Programs (N = 157)
Site (number randomized) | Location | Type | Program Involved in Study | Overall Services Provided* | Medications Historically Used for Opioid Dependence Treatment |
---|---|---|---|---|---|
Addiction Research and Treatment Corporation (n = 30) | Brooklyn, NY | Public, non-profit opiate treatment program (OTP) | Large, outpatient OTP | C, O | Methadone |
Aegis Medical Systems (n = 29) | Oxnard, CA | Public, for-profit organization of licensed OTPs | Large, outpatient OTP | C, O | Methadone, LAAM, naltrexone |
Bellevue Hospital (n = 20) | New York, NY | Public, non-profit, hospital-based substance abuse service with OTP | Large, outpatient OTP | C, O, IOP | Methadone |
Kaiser-Permanente Northwest (n = 19) | Portland, OR | Non-profit HMO | Department of Addiction Medicine within a large primary care setting | C, O, IOP, AD | Clonidine |
Mercer Trenton Addiction Science Center/Robert Wood Johnson Medical School (n = 27) | Trenton, NJ | Public, non-profit, university-based with OTP | Outpatient OTP | C, O, IOP, AD | Methadone |
Midtown Community Mental Health Center (n = 32) | Indianapolis, IN | Community Mental Health Center, public, non-profit, integrated mental health and addictions with OTP | Outpatient Detoxification Clinic at Wishard Hospital | C, O, IOP, A, AD, IR, D, F | Methadone, LAAM, non-narcotic |
IOP = intensive outpatient; O = outpatient; IR = intensive residential; LTR = long-term residential; A = aftercare; AD = ambulatory detoxification; D = day treatment, C = comprehensive service; F = family services.